About
Autologous Kidney Cell Therapy
Areas of Focus
Categories
Stem Cell & Cellular TherapyNorth & South Carolina
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
969
By Phase
PHASE3: 2PHASE1: 2PHASE2: 4
By Status
COMPLETED: 4RECRUITING: 2TERMINATED: 2WITHDRAWN: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT05286853Lead Sponsor
A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disease
PHASE3Withdrawn
Started: Jul 17, 2024 · Completed: Sep 3, 2024
NCT05918523Lead Sponsor
A Long-Term Follow-Up Study of Participants Exposed to REACT
N/ARecruiting
80 participants
Started: Dec 11, 2023 · Completed: Mar 31, 2028
NCT06790498Lead Sponsor
Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
N/AEnrolling by invitation
50 participants
Started: Nov 23, 2023 · Completed: Aug 31, 2030
NCT05694169Lead Sponsor
A Study of Participants With Chronic Kidney Disease Previously Treated With REACT
PHASE1Terminated
1 participants
Started: Jul 11, 2023 · Completed: May 13, 2024
NCT05099770Lead Sponsor
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
PHASE3Recruiting
685 participants
Started: Jan 5, 2022 · Completed: Feb 28, 2027
Locations (1)
Headquarters
Winston-Salem, NC, United States
Map
Loading map...